Khan K. Efficacy and safety of sitagliptin, metformin and pioglitazone fixed-dose combination therapy (100 mg/1000mg and 15 mg respectively) as a first-line treatment in obese type 2 diabetes with high insulin resistance. IJMBS [Internet]. 2025 Feb. 27 [cited 2026 Apr. 27];9(1):247-51. Available from: https://www.ijmbs.info/index.php/ijmbs/article/view/3064